274 related articles for article (PubMed ID: 19996270)
21. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent.
Du L; Lyle CS; Obey TB; Gaarde WA; Muir JA; Bennett BL; Chambers TC
J Biol Chem; 2004 Mar; 279(12):11957-66. PubMed ID: 14704147
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt.
Sunters A; Madureira PA; Pomeranz KM; Aubert M; Brosens JJ; Cook SJ; Burgering BM; Coombes RC; Lam EW
Cancer Res; 2006 Jan; 66(1):212-20. PubMed ID: 16397234
[TBL] [Abstract][Full Text] [Related]
23. Roles of phosphorylated JNK in esophageal squamous cell carcinomas of Kazakh ethnic.
Qin X; Zheng S; Liu T; Liu Q; Liang M; Li X; Sheyhidin I; Lu X
Mol Carcinog; 2014 Jul; 53(7):526-36. PubMed ID: 23359384
[TBL] [Abstract][Full Text] [Related]
24. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
Yan F; Wang XM; Liu ZC; Pan C; Yuan SB; Ma QM
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):287-95. PubMed ID: 20525557
[TBL] [Abstract][Full Text] [Related]
25. HDAC inhibitors suppress c-Jun/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells.
He W; Wu Y; Tang X; Xia Y; He G; Min Z; Li C; Xiong S; Shi Z; Lu Y; Yuan Z
Oncotarget; 2016 Feb; 7(6):6727-47. PubMed ID: 26734995
[TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
[TBL] [Abstract][Full Text] [Related]
27. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA
Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
[TBL] [Abstract][Full Text] [Related]
28. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway.
Tan J; Gao W; Yang W; Zeng X; Wang L; Cui X
J Thorac Cardiovasc Surg; 2021 Aug; 162(2):e143-e156. PubMed ID: 32414595
[TBL] [Abstract][Full Text] [Related]
29. Role of c-Jun N-terminal kinase isoforms in the cellular activity of melanoma cell lines.
Kogushi-Nishi H; Jinnin M; Kobayashi Y; Muchemwa FC; Hirano A; Makino T; Fukushima S; Masuguchi S; Ishihara T; Inoue Y; Ihn H
Clin Exp Dermatol; 2013 Dec; 38(8):890-6. PubMed ID: 24252081
[TBL] [Abstract][Full Text] [Related]
30. Mitogen-activated protein kinase mediates mevalonate-stimulated human mesangial cell proliferation.
Zhou X; Wang C; Tian J; Wang Y; Li Y; Hu Z; Li R
Mol Med Rep; 2015 Aug; 12(2):2643-9. PubMed ID: 25936991
[TBL] [Abstract][Full Text] [Related]
31. c-Jun N-terminal kinase 1 is required for cordycepin-mediated induction of G2/M cell-cycle arrest via p21WAF1 expression in human colon cancer cells.
Lee SJ; Moon GS; Jung KH; Kim WJ; Moon SK
Food Chem Toxicol; 2010 Jan; 48(1):277-83. PubMed ID: 19833164
[TBL] [Abstract][Full Text] [Related]
32. Specific regulation of JNK signalling by the novel rat MKK7gamma1 isoform.
Haeusgen W; Herdegen T; Waetzig V
Cell Signal; 2010 Nov; 22(11):1761-72. PubMed ID: 20633641
[TBL] [Abstract][Full Text] [Related]
33. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
34. Activation of the c-Jun NH
Fung TS; Liu DX
Cell Death Dis; 2017 Dec; 8(12):3215. PubMed ID: 29238080
[TBL] [Abstract][Full Text] [Related]
35. Leflunomide or A77 1726 protect from acetaminophen-induced cell injury through inhibition of JNK-mediated mitochondrial permeability transition in immortalized human hepatocytes.
Latchoumycandane C; Seah QM; Tan RC; Sattabongkot J; Beerheide W; Boelsterli UA
Toxicol Appl Pharmacol; 2006 Nov; 217(1):125-33. PubMed ID: 16979204
[TBL] [Abstract][Full Text] [Related]
36. Oppositional regulation of Noxa by JNK1 and JNK2 during apoptosis induced by proteasomal inhibitors.
Pietkiewicz S; Sohn D; Piekorz RP; Grether-Beck S; Budach W; Sabapathy K; Jänicke RU
PLoS One; 2013; 8(4):e61438. PubMed ID: 23593480
[TBL] [Abstract][Full Text] [Related]
37. Fullerene derivative prevents cellular transformation induced by JAK2 V617F mutant through inhibiting c-Jun N-terminal kinase pathway.
Funakoshi-Tago M; Nagata T; Tago K; Tsukada M; Tanaka K; Nakamura S; Mashino T; Kasahara T
Cell Signal; 2012 Nov; 24(11):2024-34. PubMed ID: 22750290
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of c-Jun N-terminal kinase sensitizes tumor cells to flavonoid-induced apoptosis through down-regulation of JunD.
Kook SH; Son YO; Jang YS; Lee KY; Lee SA; Kim BS; Lee HJ; Lee JC
Toxicol Appl Pharmacol; 2008 Mar; 227(3):468-76. PubMed ID: 18078968
[TBL] [Abstract][Full Text] [Related]
39. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
[TBL] [Abstract][Full Text] [Related]
40. C-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoform.
Pawate S; Bhat NR
Antioxid Redox Signal; 2006; 8(5-6):903-9. PubMed ID: 16771680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
